HIV reservoirs and strategies for eradication

  • Smith M
  • Wightman F
  • Lewin S
  • 57

    Readers

    Mendeley users who have this article in their library.
  • 35

    Citations

    Citations of this article.

Abstract

Combination antiretroviral therapy (cART) has led to a reduction in morbidity and mortality in HIV-infected patients but therapy is lifelong and there is no cure for HIV. The major barriers to cure include HIV latency, which has been identified in different T-cell subsets, as well as persistence of HIV in anatomical reservoirs. We review recent developments in our understanding of the major reservoirs of HIV in patients on cART as well as how latency is established and maintained in T cells. Finally, we review the scientific rationale of and clinical experience with pharmacotherapeutic strategies aimed at eliminating latently infected cells.

Author-supplied keywords

  • Activation
  • Antiretroviral treatment
  • CD4+ Tcells
  • Eradication
  • Gastrointestinal tract
  • Latency
  • Reservoirs
  • Tissue
  • Viremia

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text

Authors

  • Miranda Z. Smith

  • Fiona Wightman

  • Sharon R. Lewin

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free